| 000 | 01751 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513115818.0 | ||
| 264 | 0 | _c19970703 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(97)00081-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleckenstein, A E | |
| 245 | 0 | 0 |
_aMethamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cApr 1997 |
||
| 300 |
_a179-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarrier Proteins _xdrug effects |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFluoxetine _xpharmacology |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xdrug effects |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 |
_aMethamphetamine _xpharmacology |
| 650 | 0 | 4 | _aNerve Tissue Proteins |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSerotonin Plasma Membrane Transport Proteins |
| 650 | 0 | 4 |
_aTryptophan Hydroxylase _xdrug effects |
| 650 | 0 | 4 |
_aVisual Cortex _xdrug effects |
| 700 | 1 | _aBeyeler, M L | |
| 700 | 1 | _aJackson, J C | |
| 700 | 1 | _aWilkins, D G | |
| 700 | 1 | _aGibb, J W | |
| 700 | 1 | _aHanson, G R | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 324 _gno. 2-3 _gp. 179-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(97)00081-2 _zAvailable from publisher's website |
| 999 |
_c9127147 _d9127147 |
||